摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(dibenzylidene propylene diamine o,o'-dihydroxo) oxo vanadium (IV) | 22785-41-7

中文名称
——
中文别名
——
英文名称
(dibenzylidene propylene diamine o,o'-dihydroxo) oxo vanadium (IV)
英文别名
propan-1,2-diylbis(N,N'-salicylideneiminato)oxovanadium(IV);N,N'-bis(salicylidene)propylenediaminatooxovanadium(IV);VO(N,N'-1,2-propylenebis-salicylideneaminato);VO(N,N'-bis(salicylidene)-1,2-diaminopropane)
(dibenzylidene propylene diamine o,o'-dihydroxo) oxo vanadium (IV)化学式
CAS
22785-41-7;36537-60-7;29876-29-7;1021603-25-7
化学式
C17H16N2O3V
mdl
——
分子量
347.267
InChiKey
ODGRTWPIUGNSPE-IZJQDONGSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    (dibenzylidene propylene diamine o,o'-dihydroxo) oxo vanadium (IV)氢溴酸乙腈 为溶剂, 以74%的产率得到dibromo[propan-1,2-diylbis(N,N'-salicylideneiminato)]vanadium(IV)
    参考文献:
    名称:
    新的四齿席夫碱,它们的氧钒(IV)配合物以及双齿席夫碱与钒(III)的某些配合物
    摘要:
    摘要描述了在两个亚氨基氮原子之间包含一个,两个或三个碳原子的四齿席夫碱双阴离子新的钒(IV)配合物。这些化合物是单核的或高分子的,如v(V = O)的值所示,具体取决于席夫碱的二价阴离子。没有证据表明电子会沿着聚合物链发生离域化。还分离了一些双齿席夫碱单阴离子钒(III)配合物。报道了[VO(2-OC6H4CHNH)2]的晶体结构和[V(Prhap)3]·甲苯[HPrhap = 2-HOC6H4C(Me)NCH2CH2Me]的结构的初步数据。
    DOI:
    10.1016/s0277-5387(96)00436-6
  • 作为产物:
    描述:
    (dibenzylidene propylene diamine o,o'-dihydroxo) vanadium (III) hydrogensulfate 以 为溶剂, 生成 (dibenzylidene propylene diamine o,o'-dihydroxo) oxo vanadium (IV)
    参考文献:
    名称:
    Bielig, H. J.; Bayer, E., Liebigs Annalen der Chemie, 1953, vol. 580, p. 135 - 158
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • A vanadyl donor bond to tin in a heterobimetallic complex: the crystal structure of SnPh<sub>3</sub>Cl·VO(salpren)(H<sub>2</sub>salpren =N,N′-1,2-propylenebis-salicylideneamine)
    作者:Brenda Cashin、Desmond Cunningham、John F. Gallagher、Pat McArdle、Tim Higgins
    DOI:10.1039/c39890001445
    日期:——
    The title complex has an adduct structure in which the vanadyl salicylaldimine forms a donor bond through the vanadyl oxygen to tin, thereby generating an almost linear V–O–Sn moiety.
    标题复合物具有加合物结构,其中氧水杨醛亚胺通过氧氧与形成供体键,从而生成几乎线性的V–O–Sn部分。
  • Reporting a New Class of Divanadium(V) Compounds Connected by an Unsupported Hydroxo Bridge
    作者:Pabitra Baran Chatterjee、Debdas Mandal、Anandalok Audhya、Ki-Young Choi、Akira Endo、Muktimoy Chaudhury
    DOI:10.1021/ic702286h
    日期:2008.5.1
    X-ray diffraction analyses. The molecules of 1- 3 have centrosymmetric structures with each vanadium center having a distorted octahedral geometry. The bridging OH (-) group is located trans to the terminal VO t bond. The latter exerts strong trans labilizing influence to set the participating vanadium centers apart by about 4.1 A. These separations are by far the largest (e.g., V...V#, 4.131 A in 1) among
    双核氧(V)化合物[LV(V)O(mu-OH)OV(V)L](PF6)[H2L = N,N'-叔乙烯双(亚胺)(H 2Salen)及其衍生物]( 1-3)是通过在添加的NH 4PF 6存在下将V(IV)OL前体在THF中进行空气氧化而获得的。氧化的(V)可能会从溶剂中的残留分中提取OH(-)配体。如单晶X射线衍射分析所证实的那样,这些化合物的属中心之间保留有无支撑的羟基桥连基。1-3的分子具有中心对称结构,每个中心具有扭曲的八面体几何形状。桥连的OH(-)基团位于末端VO t键的反式位置。后者施加强大的反通斜影响,使参与的中心相距约4.1A。迄今为止,这些分离是所有含无载体羟基桥的双核化合物中最大的分离(例如,V ... V#,4.131 A)。如(1)1 H NMR光谱法所确定的,该络合物还在溶液中保持其身份。电化学上,如循环伏安法在乙腈中研究的1-3的行为非常有趣,每个
  • Gmelin Handbuch der Anorganischen Chemie, Gmelin Handbook: V: MVol.B2, 162, page 713 - 714
    作者:
    DOI:——
    日期:——
  • 1:1 Adducts of triphenyltin chloride with oxovanadium(IV) tetradentate Schiff-base complexes
    作者:Nosheen F. Choudhary、Peter B. Hitchcock、G.Jeffery Leigh、Seik Weng Ng
    DOI:10.1016/s0020-1693(99)00230-3
    日期:1999.10
    Triphenyltin chloride-N,N'-ethylenebis(salicylideneiminato)oxovanadium(IV) (1/1), which crystallises from acetonitrile with half a molecule of the solvent, is a heterodinuclear entity that displays an almost linear tin-oxygen-vanadium unit [Sn-O-V = 172.7(2)degrees; Sn-O = 2.382(2), V-O = 1.614(3) Angstrom]. The tin atom shows approximately trigonal bipyramidal coordination in the adduct with the axial sites occupied by the O and Cl atoms. On the other hand, the vanadium atom is in square-pyramidal coordination, and the vanadium-containing moiety is 68% displaced along the Berry pseudorotation pathway from trigonal bipyramidal towards square pyramidal, compared with the 83% mean displacement for [VO(salen)] itself. The corresponding displacements for the vanadium moiety in Ph3SnCl . VO(hap-1,2-pn). 2CH(3)CN are 94% [Sn-O = 2.405(6), V-O = 1.627(6) Angstrom; Sn-O-V = 175.5(3)degrees] and 89% in Ph3SnCl . VO[salen(3-OMe)(2)]. CH3CN [Sn-O = 2.428(2), V-O = 1.625(2) Angstrom; Sn-O-V = 167.5(1)degrees] [H(2)hap-1,2-pn = N,N'-methylmethylenebis(2-phenolatoacetophenoneimine); H(2)salen(3-OMe)(2) = N,N'-ethylenebis(3-methoxysalicylideneimine)]. The [VO(salen)] adduct of N-triphenylstannyl-1,2-benzisothiazol-3(2H)-one 1,1-dioxide has also been synthesised, and characterised by spectroscopic measurements. (C) 1999 Elsevier Science S.A. All rights reserved.
  • Binuclear metal complexes XVII. Vanadium(V)-copper(I) hetero-metal binuclear complexes prepared from oxovanadium(IV) complexes with quadridentate schiff bases and copper(II) halides
    作者:H. Okawa、S. Kida
    DOI:10.1016/s0020-1693(00)94770-4
    日期:1977.1
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)